| 1 |
33671452 | Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway. | 2021 Feb 17 |
2 |
| 2 |
34596810 | Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways. | 2021 Nov |
3 |
| 3 |
32457362 | Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways. | 2020 Aug |
2 |
| 4 |
29609689 | Regorafenib delays the proliferation of hepatocellular carcinoma by inducing autophagy. | 2018 Apr 2 |
1 |
| 5 |
29783729 | Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. | 2018 May 19 |
2 |
| 6 |
28166200 | Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. | 2017 Jun 22 |
1 |
| 7 |
28978118 | Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer. | 2017 Sep 15 |
1 |